Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted (89)Zr-Pertuzumab PET/CT

BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-targeted therapies are successful in patients with HER2-positive malignancies; however, spatial and temporal heterogeneity of HER2 expression may prevent identification of optimal patients for these therapies. PURPOSE: To determine whether...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiology
Autors principals: Ulaner, Gary A., Carrasquillo, Jorge A., Riedl, Christopher C., Yeh, Randy, Hatzoglou, Vaios, Ross, Dara S., Jhaveri, Komal, Chandarlapaty, Sarat, Hyman, David M., Zeglis, Brian M., Lyashchenko, Serge K., Lewis, Jason S.
Format: Artigo
Idioma:Inglês
Publicat: Radiological Society of North America 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543717/
https://ncbi.nlm.nih.gov/pubmed/32515679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2020192828
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars